Cargando…
Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets
Systemic delivery of conventional chemotherapies can cause negative systemic toxicity, including reduced immunity and damage to organs such as the heart and kidneys—limiting the maximum dose that can be administered. Targeted therapies appear to address this problem by having a specific target while...
Autores principales: | Murphy, Emily M., Centner, Connor S., Bates, Paula J., Malik, Mohammad T., Kopechek, Jonathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241745/ https://www.ncbi.nlm.nih.gov/pubmed/32437399 http://dx.doi.org/10.1371/journal.pone.0233466 |
Ejemplares similares
-
AS1411-conjugated gold nanospheres and their potential for breast cancer therapy
por: Malik, Mohammad T., et al.
Publicado: (2015) -
AS1411-functionalized delivery nanosystems for targeted cancer therapy
por: Kozani, Pooria Safarzadeh, et al.
Publicado: (2021) -
Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles
por: Mehrnia, Somayeh Sadat, et al.
Publicado: (2021) -
Progress in cancer drug delivery based on AS1411 oriented nanomaterials
por: Tong, Xin, et al.
Publicado: (2022) -
Novel nanosized AS1411–chitosan–BODIPY conjugate for molecular fluorescent imaging
por: Taki, Setareh, et al.
Publicado: (2019)